Automated multi-parameter measurement of cardiomyocytes dynamics with digital holographic microscopy

Optics Express
|June 16, 2015
PubMed

Insights

Digital holographic microscopy (DHM) offers a new method for analyzing cardiomyocyte function during drug safety testing. This technique provides dynamic, quantitative phase profiles for improved cell analysis and drug toxicity screening.

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Pharmacology

Background:

  • Preclinical assessment of cardiac liability is crucial for new chemical entities.
  • Conventional imaging techniques lack detail and contrast for transparent cell structures.
  • Accurate analysis of cardiomyocyte function is vital for drug safety.

Purpose of the Study:

  • To introduce digital holographic microscopy (DHM) for quantitative analysis of cardiomyocytes.
  • To demonstrate automated analysis of cardiomyocyte dynamics for drug screening.
  • To establish DHM as a new paradigm in drug toxicity testing.

Main Methods:

  • Digital holographic microscopy (DHM) was integrated with information processing algorithms.
  • Automated algorithms analyzed dynamic quantitative phase profiles of beating cardiomyocytes.
  • Physiological states of resting cardiomyocytes were characterized using DHM phase signals.

Main Results:

  • DHM successfully provided dynamic quantitative phase profiles of cardiomyocytes.
  • Relevant cardiomyocyte parameters were obtained through automated DHM signal analysis.
  • The method enabled characterization of the physiological state of resting cardiomyocytes.

Conclusions:

  • DHM offers a robust, automated method for quantitative analysis of cardiomyocyte dynamics.
  • This approach enhances drug safety testing and compound selection.
  • DHM presents a novel paradigm for drug toxicity screening.

Related Concept Videos